Search Results - Kargus, Katherine

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations

    Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations by Adib, Elio, Klonowska, Katarzyna, Giannikou, Krinio, Do, Khanh T, Pruitt-Thompson, Solida, Bhushan, Ketki, Milstein, Matthew I, Hedglin, Jennifer, Kargus, Katherine E, Sholl, Lynette M, Tsuji, Junko, Hyman, David M, Sisk, Anne, Shapiro, Geoffrey I, Vargas, Hebert A, Harding, James J, Voss, Martin H, Iyer, Gopa, Kwiatkowski, David J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials

    Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials by Mondaca, Sebastian P., Liu, Dazhi, Flynn, Jessica R., Badson, Sandy, Hamaway, Stefan, Gounder, Mrinal M., Khalil, Danny N., Drilon, Alexander E., Li, Bob T., Jhaveri, Komal L., Schram, Alison M., Kargus, Katherine E., Kasler, Mary Kate, Blauvelt, Natalie M., Segal, Neil H., Capanu, Marinela, Callahan, Margaret K., Hyman, David M., Gambarin‐Gelwan, Maya, Harding, James J.

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers

    Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers by Rustgi, Naryan, Maria, Ann, Toumbacaris, Nicolas, Zhao, HuiYong, Kargus, Katherine, Bryant, Morgan, Waksmundzki, Alexandra, Aricescu, Ilinca, Lefkowitz, Robert A, Li, Bob T, Chou, Joanne, Capanu, Marinela, de Stanchina, Elisa, Misale, Sandra, Shia, Jinru, Yaeger, Rona

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    ABT-888 Plus Bendamustine Is Safe and Has Shown Preliminary Efficacy In Patients With Lymphoma

    ABT-888 Plus Bendamustine Is Safe and Has Shown Preliminary Efficacy In Patients With Lymphoma by Gerecitano, John F., Schwartz, Gary K, Carvajal, Richard, Fury, Matthew, Konner, Jason, Hyman, David M., Gounder, Mrinal, Gajria, Devika, Teitcher, Jerrold, Zhang, Zhigang, Moskowitz, Craig H., Beumer, Jan H, Chen, Alice, Little, Richard F, France, Fallon, Whang, Juho, Winkelman, Jennifer, Stasi, Megan, Russell, Corey, Cazeau, Naomi, Kargus, Katherine, Zelenetz, Andrew D.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: